CareDx Insiders Sold US$1.4m Of Shares Suggesting Hesitancy
CareDx Insiders Sold US$1.4m Of Shares Suggesting Hesitancy
The fact that multiple CareDx, Inc (NASDAQ:CDNA) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.
過去一年裏，CareDx, Inc (納斯達克:CDNA)的多位內部人士拋售了大量股票，這可能引起了投資者的注意。分析內部交易時，了解內部人員是買還是賣股票通常更有價值，因爲後者傳遞出一種模糊的信息。然而，當多個內部人士在一段特定時間內拋售股票時，股東應該注意，因爲這可能是一個紅旗。
Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.
雖然我們認爲股東不應僅僅跟隨內部人士的交易，但邏輯告訴我們，應該注意內部人士是購買還是出售股票。
The Last 12 Months Of Insider Transactions At CareDx
事實上，根據我們的記錄，在過去十二個月內，亞歷山大·約翰遜的最近賣出是CareDx股票中由內部個人進行的最大規模的交易。所以可以肯定的是，有一個內部人士認爲該股票的當前價格31.54美元左右是合適的。雖然內部人士的拋售是一種負面情況，但對我們來說，如果股票是以更低的價格出售，則更爲負面。在這種情況下，大宗交易發生在當前價格左右，所以情況還不算太糟糕（但也不是積極的）。
In fact, the recent sale by Alexander Johnson was the biggest sale of CareDx shares made by an insider individual in the last twelve months, according to our records. So what is clear is that an insider saw fit to sell at around the current price of US$31.54. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).
過去一年內，CareDx的內部人士未購買任何股票。您可以在下面看到內部交易（公司和個人）在過去12個月內的可視化圖表。如果您想知道確切的賣出者、賣出數量和時間，請點擊下圖！
CareDx insiders didn't buy any shares over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!
過去一年裏，CareDx的內部人士未購買任何股票。您可以在下面看到內部交易（公司和個人）在過去12個月內的可視化圖表。如果您想知道確切的賣出者、賣出數量和時間，請點擊下圖！
If you are like me, then you will not want to miss this free list of small cap stocks that are not only being bought by insiders but also have attractive valuations.
如果您和我一樣，您就不會錯過這個免費的小盤股票列表，這些股票不僅被內部人士購買，而且估值也很有吸引力。
Insiders At CareDx Have Sold Stock Recently
Caredx內部人士最近賣出了股票。
The last three months saw significant insider selling at CareDx. In total, insiders dumped US$1.4m worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.
過去三個月，Caredx的內部人士大量拋售了股票，總共價值140萬美元，在這段時間內我們沒有記錄到任何買入。總體上，這讓我們有些謹慎，但這並不是決定一切的因素。
Insider Ownership
內部人員持股情況
I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. CareDx insiders own about US$42m worth of shares. That equates to 2.6% of the company. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.
我喜歡查看公司內部人員持有多少股份，以幫助判斷他們與公司內部人員的利益共享程度。通常，內部人員持股比例越高，內部人員越有動力爲公司長期發展而努力。CareDx的內部人員持有價值約爲4200萬美元的股份，相當於公司的2.6%。這種程度的內部人員持股比例不錯，但還不足以引人注目。它確實表明了相當程度上的利益共享。
What Might The Insider Transactions At CareDx Tell Us?
CareDx的內部交易能告訴我們些什麼呢？
Insiders sold CareDx shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. So we'd only buy after careful consideration. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. In terms of investment risks, we've identified 3 warning signs with CareDx and understanding them should be part of your investment process.
內部人員最近賣出了CareDx的股票，但沒有買入。根據過去的十二個月數據，我們的數據沒有顯示任何內部人員的買入行爲。內部人員持股比例並不是特別高，因此這項分析使我們對該公司持謹慎態度。因此，只有經過仔細考慮後，我們才會買入。了解內部人員在買賣方面的動態固然有幫助，但了解特定公司面臨的風險也同樣重要。在投資風險方面，我們已經發現了CareDx的三個警示信號，了解它們應該成爲您投資過程的一部分。
But note: CareDx may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
但請注意：CareDx可能不是最佳的股票選擇。因此，您可以參考這份免費的高roe和低債務的有趣公司列表。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
對於本文而言，內部人是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置，但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋？對內容有任何疑慮？請直接與我們聯繫。或者，發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論，只使用公正的方法論，我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議，也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意，我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。
譯文內容由第三人軟體翻譯。